{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:55:36Z","timestamp":1780944936626,"version":"3.54.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T00:00:00Z","timestamp":1477267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T00:00:00Z","timestamp":1477267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00436-016-5278-9","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T01:46:34Z","timestamp":1477273594000},"page":"21-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neurocysticercosis: a review on status in India, management, and current therapeutic interventions"],"prefix":"10.1007","volume":"116","author":[{"given":"Rumana","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahmeena","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Balapure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"5278_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1017\/S0031182000060686","volume":"101","author":"JC Allan","year":"1990","unstructured":"Allan JC, Avila G, Garcia NJ et al (1990) Immunodiagnosis of taeniasis by coproantigen detection. Parasitology 101:473\u2013477","journal-title":"Parasitology"},{"key":"5278_CR2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4269\/ajtmh.1996.54.352","volume":"54","author":"JC Allan","year":"1996","unstructured":"Allan JC, Velasquez-Tohom M, Torres-Alvarez R et al (1996) Field trial of the coproantigen-based diagnosis of Taenia solium taeniasis by enzyme linked immunosorbent assay. Am J Trop Med Hyg 54:352\u2013356","journal-title":"Am J Trop Med Hyg"},{"key":"5278_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ijpara.2010.01.006","volume":"40","author":"E Assana","year":"2002","unstructured":"Assana E, Kyngdon CT, Gauci CG et al (2002) Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 40:515\u2013519","journal-title":"Int J Parasitol"},{"key":"5278_CR4","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1128\/AAC.01296-10","volume":"55","author":"JK Baird","year":"2011","unstructured":"Baird JK (2011) Resistance to chloroquine unhinges vivax malaria therapeutics. Antimicrob Agents Chemother 55:1827\u20131830","journal-title":"Antimicrob Agents Chemother"},{"key":"5278_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/1471-2164-10-488","volume":"10","author":"DH Bos","year":"2009","unstructured":"Bos DH, Mayfield C, Minchella DJ (2009) Analysis of regulatory protease sequences identified through bioinformatic data mining of the Schistosoma mansoni genome. BMC Genomics 10:488","journal-title":"BMC Genomics"},{"key":"5278_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.idc.2012.02.001","volume":"26","author":"E Brunetti","year":"2012","unstructured":"Brunetti E, White AC (2012) Cestode infestations: hydatid disease and cysticercosis. Infect Dis Clin North Am 26:421\u2013435","journal-title":"Infect Dis Clin North Am"},{"key":"5278_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.actatropica.2009.04.006","volume":"111","author":"JM Bygott","year":"2009","unstructured":"Bygott JM, Chiodini PL (2009) Praziquantel: neglected drug? Ineffective treatment? Or therapeutic choice in cystic hydatid disease? Acta Trop 111:95\u2013101","journal-title":"Acta Trop"},{"key":"5278_CR8","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.3748\/wjg.v12.i39.6366","volume":"12","author":"R Canete","year":"2006","unstructured":"Canete R, Escobedo AA, Gonzalez ME et al (2006) Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children. World J Gastroenterol 12:6366\u20136370","journal-title":"World J Gastroenterol"},{"key":"5278_CR9","doi-asserted-by":"publisher","first-page":"e1152","DOI":"10.1371\/journal.pntd.0001152","volume":"5","author":"H Carabin","year":"2011","unstructured":"Carabin H, Ndimubanzi PC, Budke CM et al (2011) Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5:e1152","journal-title":"PLoS Negl Trop Dis"},{"key":"5278_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3201\/eid0303.970324","volume":"3","author":"E Carlton","year":"1997","unstructured":"Carlton E, Hector HG, Robert H et al (1997) Controversies in the management of cysticercosis. Emerg Infect Dis 3:403\u2013405","journal-title":"Emerg Infect Dis"},{"key":"5278_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nature16033","volume":"527","author":"CJ Chandy","year":"2015","unstructured":"Chandy CJ, H\u00e9l\u00e8ne C, Silvia MM et al (2015) Global research priorities for infections that affect the nervous system. Nature 527:178\u2013186","journal-title":"Nature"},{"key":"5278_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1046\/j.1365-3156.1998.00257.x","volume":"3","author":"F Cobo","year":"1998","unstructured":"Cobo F, Yarnoz C, Sesma B et al (1998) Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatisosis caused by Echinococcus granulosus. Trop Med Int Health 3:462\u2013466","journal-title":"Trop Med Int Health"},{"key":"5278_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJM199601113340216","volume":"334","author":"T Corona","year":"1996","unstructured":"Corona T, Lugo R, Medina R et al (1996) Single-day praziquantel therapy for neurocysticercosis. N Engl J Med 334:125","journal-title":"N Engl J Med"},{"key":"5278_CR14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0035-9203(89)90340-4","volume":"83","author":"D Correa","year":"1989","unstructured":"Correa D, Sandoval MA, Harrison LJ et al (1989) Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R Soc Trop Med Hyg 83:814\u2013816","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5278_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","volume":"103","author":"RN Davidson","year":"2009","unstructured":"Davidson RN, den Boer M, Ritmeijer K (2009) Paromomycin. Trans R Soc Trop Med Hyg 103:653\u2013660","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5278_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1179\/2047773212Y.0000000025","volume":"106","author":"OH Del Brutto","year":"2012","unstructured":"Del Brutto OH (2012) Diagnostic criteria for neurocysticercosis, revisited. Pathog Glob Health 106:299\u2013304","journal-title":"Pathog Glob Health"},{"key":"5278_CR17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/clinids\/17.4.730","volume":"17","author":"OH Del Brutto","year":"1993","unstructured":"Del Brutto OH, Sotelo J, Roman GC (1993) Therapy for neurocysticercosis: a reappraisal. Clin Infect Dis 17:730\u2013735","journal-title":"Clin Infect Dis"},{"key":"5278_CR18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1212\/WNL.52.5.1079","volume":"52","author":"OH Del Brutto","year":"1999","unstructured":"Del Brutto OH, Campos X, S\u00e1nchez J et al (1999) Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology 52:1079\u20131081","journal-title":"Neurology"},{"key":"5278_CR19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fonc.2013.00250","volume":"3","author":"P den Hollander","year":"2013","unstructured":"den Hollander P, Savage MI, Brown PH (2013) Targeted therapy for breast cancer prevention. Front Oncol 3:250","journal-title":"Front Oncol"},{"key":"5278_CR20","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/cancers5031163","volume":"5","author":"N Di Santo","year":"2013","unstructured":"Di Santo N, Ehrisman J (2013) Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose? Cancers 5:1163\u20131176","journal-title":"Cancers"},{"key":"5278_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0303-8467(00)00110-4","volume":"102","author":"P l EJ","year":"2000","unstructured":"EJ P l, Garc\u00eda HH, Custodio N et al (2000) Short regimen of praziquantel in the treatment of single brain enhancing lesions. Clin Neurol Neurosurg 102:215\u2013218","journal-title":"Clin Neurol Neurosurg"},{"key":"5278_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0035-9203(02)90095-7","volume":"96","author":"A Erhart","year":"2002","unstructured":"Erhart A, Dorny P, Van De N et al (2002) Taenia solium cysticercosis in a village in northern Viet Nam: sero prevalence study using an ELISA for detecting circulating antigen. Trans R Soc Trop Med Hyg 96:270\u2013272","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5278_CR23","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1645\/GE-297R","volume":"90","author":"G Escobedo","year":"2004","unstructured":"Escobedo G, Larralde C, Chavarria A et al (2004) Molecular mechanisms involved in the differential effects of sex steroids on the reproduction and infectivity of Taenia crassiceps. J Parasitol 90:1235\u20131244","journal-title":"J Parasitol"},{"key":"5278_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.pt.2005.09.013","volume":"21","author":"G Escobedo","year":"2005","unstructured":"Escobedo G, Roberts CW, Carrero JC et al (2005) Parasite regulation by host hormones: an old mechanism of host exploitation? Trends Parasitol 21:588\u2013593","journal-title":"Trends Parasitol"},{"key":"5278_CR25","first-page":"591079","volume":"2010","author":"G Escobedo","year":"2010","unstructured":"Escobedo G, Camacho-Arroyo I, Hernandez-Hernandez OT et al (2010a) Progesterone induces scolex evagination of the human parasite Taenia solium: evolutionary implications to the host-parasite relationship. J Biomed Biotechnol 2010:591079","journal-title":"J Biomed Biotechnol"},{"key":"5278_CR26","first-page":"747121","volume":"2010","author":"G Escobedo","year":"2010","unstructured":"Escobedo G, Soldevila G, Ortega-Pierres G et al (2010b) A new MAP kinase protein involved in estradiol-stimulated reproduction of the helminth parasite Taenia crassiceps. J Biomed Biotechnol 2010:747121","journal-title":"J Biomed Biotechnol"},{"key":"5278_CR27","doi-asserted-by":"publisher","first-page":"280496","DOI":"10.1155\/2013\/280496","volume":"2013","author":"G Escobedo","year":"2013","unstructured":"Escobedo G, Palacios-Arreola MI, Olivos A et al (2013) Tamoxifen treatment in hamsters induces protection during taeniasis by Taenia solium. Biomed Res Int 2013:280496","journal-title":"Biomed Res Int"},{"key":"5278_CR28","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1128\/IAI.72.9.5292-5297.2004","volume":"7","author":"A Flisser","year":"2004","unstructured":"Flisser A, Gauci CG, Zoli A et al (2004) Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun 7:5292\u20135297","journal-title":"Infect Immun"},{"key":"5278_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/IJGM.S73249","volume":"8","author":"YF Fogang","year":"2015","unstructured":"Fogang YF, Savadogo AA, Camara A et al (2015) Managing neurocysticercosis: challenges and solution. Int J Gen Med 8:333\u2013344","journal-title":"Int J Gen Med"},{"key":"5278_CR30","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1212\/WNL.48.5.1421","volume":"48","author":"HH Garc\u00eda","year":"1997","unstructured":"Garc\u00eda HH, Gilman RH, Horton J et al (1997) Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology 48:1421\u20131427","journal-title":"Neurology"},{"key":"5278_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0035-9203(00)90228-1","volume":"94","author":"HH Garcia","year":"2000","unstructured":"Garcia HH, Parkhouse RM, Gilman RH et al (2000) Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg 94:673\u2013676","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5278_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.15.4.747-756.2002","volume":"15","author":"HH Garc\u00eda","year":"2002","unstructured":"Garc\u00eda HH, Evans CA, Nash TE et al (2002) Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 15:747\u2013756","journal-title":"Clin Microbiol Rev"},{"key":"5278_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMoa031294","volume":"350","author":"HH Garcia","year":"2004","unstructured":"Garcia HH, Pretell EJ, Gilman RH, Cysticercosis Working Group in Peru et al (2004) A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350:249\u2013258","journal-title":"N Engl J Med"},{"key":"5278_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2125.2011.03945.x","volume":"72","author":"HH Garcia","year":"2011","unstructured":"Garcia HH, Lescano AG, Lanchote VL, Cysticercosis Working Group in Peru et al (2011) Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol 72:77\u201384","journal-title":"Br J Clin Pharmacol"},{"key":"5278_CR35","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S1474-4422(14)70094-8","volume":"13","author":"HH Garcia","year":"2014","unstructured":"Garcia HH, Nash TE, Del Brutto OH (2014) Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13:1202\u20131215","journal-title":"Lancet Neurol"},{"key":"5278_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/00034983.1996.11813026","volume":"90","author":"JM Gardner","year":"1996","unstructured":"Gardner JM, Grantham-McGregor S, Baddeley A (1996) Trichuris trichiura infection and cognitive function in Jamaican school children. Ann Trop Med Parasitol 90:55\u201363","journal-title":"Ann Trop Med Parasitol"},{"key":"5278_CR37","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00436-002-0673-9","volume":"88","author":"R Gonz\u00e1lez","year":"2002","unstructured":"Gonz\u00e1lez R, Mendoza-Hern\u00e1ndez G, Plancarte A (2002) Purification of Taenia solium cystcerci superoxide dismutase and myoglobin co-purification. Parasitol Res 88:881\u2013887","journal-title":"Parasitol Res"},{"key":"5278_CR38","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4269\/ajtmh.2005.72.837","volume":"72","author":"AE Gonzalez","year":"2005","unstructured":"Gonzalez AE, Gauci CG, Barber D et al (2005) Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg 72:837\u2013839","journal-title":"Am J Trop Med Hyg"},{"key":"5278_CR39","first-page":"185","volume":"4","author":"P Gordana","year":"2014","unstructured":"Gordana P, Urs D, Benjamin S et al (2014) Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol 4:185\u2013200","journal-title":"Int J Parasitol"},{"key":"5278_CR40","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.steroids.2011.05.003","volume":"76","author":"IE Guadalupe","year":"2011","unstructured":"Guadalupe IE, Escobedo G, Nava-Castroc K et al (2011) A helminth cestode parasite expresses an estrogen-binding protein resembling a classic nuclear estrogen receptor. Steroids 76:1149\u20131159","journal-title":"Steroids"},{"key":"5278_CR41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4269\/ajtmh.2009.81.433","volume":"81","author":"MC Guezala","year":"2009","unstructured":"Guezala MC, Rodriguez S, Zamora H et al (2009) Development of a species-specific coproantigen ELISA for human Taenia solium taeniasis. Am J Trop Med Hyg 81:433\u2013437","journal-title":"Am J Trop Med Hyg"},{"key":"5278_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S003118200005006X","volume":"83","author":"A Hall","year":"1981","unstructured":"Hall A, Latham MC, Crompton DW et al (1981) Taenia saginata (Cestoda) in western Kenya: the reliability of fecal examinations in diagnosis. Parasitology 83:91\u2013101","journal-title":"Parasitology"},{"key":"5278_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/CVI.00339-09","volume":"17","author":"S Handali","year":"2010","unstructured":"Handali S, Klarman M, Gaspard AN et al (2010a) Multi antigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis. Clin Vaccine Immunol 17:68\u201372","journal-title":"Clin Vaccine Immunol"},{"key":"5278_CR44","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1128\/CVI.00511-09","volume":"17","author":"S Handali","year":"2010","unstructured":"Handali S, Klarman M, Gaspard AN et al (2010b) Development and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans. Clin Vaccine Immunol 17:631\u2013637","journal-title":"Clin Vaccine Immunol"},{"key":"5278_CR45","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2307\/3281901","volume":"71","author":"DD Heath","year":"1985","unstructured":"Heath DD, Lawrence SB, Glennie A et al (1985) The use of excretory and secretory antigens of the scolex of Taenia ovis for the sero diagnosis of infection in dogs. J Parasitol 71:192\u2013199","journal-title":"J Parasitol"},{"key":"5278_CR46","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1017\/S003118200999117X","volume":"137","author":"A Hemphill","year":"2010","unstructured":"Hemphill A, Stadelmann B, Scholl S et al (2010) Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes. Parasitology 137:569\u2013587","journal-title":"Parasitology"},{"key":"5278_CR47","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1128\/AAC.01159-06","volume":"51","author":"PS Hoffman","year":"2007","unstructured":"Hoffman PS, Sisson G, Croxen MA et al (2007) Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob Agents Chemother 51:868\u2013876","journal-title":"Antimicrob Agents Chemother"},{"key":"5278_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00351766","volume":"41","author":"B Holmstedt","year":"1978","unstructured":"Holmstedt B, Nordgren I, Sandoz M et al (1978) Metrifonate. Summary of toxicological and pharmacological information available. Arch Toxicol 41:3\u201329","journal-title":"Arch Toxicol"},{"key":"5278_CR49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4269\/ajtmh.1998.59.291","volume":"59","author":"A Ito","year":"1998","unstructured":"Ito A, Plancarte A, Ma L et al (1998) Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis. Am J Trop Med Hyg 59:291\u2013294","journal-title":"Am J Trop Med Hyg"},{"key":"5278_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1751-0813.1985.tb14142.x","volume":"62","author":"DJ Jenkins","year":"1985","unstructured":"Jenkins DJ, Rickard MD (1985) Specific antibody responses to Taenia hydatigena, Taenia pisiformis and Echinococcus granulosus infection in dogs. Aust Vet J 62:72\u201378","journal-title":"Aust Vet J"},{"key":"5278_CR51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3347\/kjp.2013.51.2.259","volume":"51","author":"HK Jeon","year":"2013","unstructured":"Jeon HK, Yong TS, Sohn WM et al (2013) Current status of human taeniasis in Lao People\u2019s Democratic Republic. Korean J Parasitol 51:259\u2013263","journal-title":"Korean J Parasitol"},{"key":"5278_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.parint.2005.11.040","volume":"55","author":"P Kern","year":"2006","unstructured":"Kern P (2006) Medical treatment of echinococcosis under the guidance of Good Clinical Practice. Parasitol Int 55:273\u2013282","journal-title":"Parasitol Int"},{"key":"5278_CR53","first-page":"51","volume":"49","author":"S Khurana","year":"2006","unstructured":"Khurana S, Aggarwal A, Malla N (2006) Prevalence of anticysticercus antibodies in slum, rural and urban populations in and around Union territory, Chandigarh. Indian J Pathol Microbiol 49:51\u201353","journal-title":"Indian J Pathol Microbiol"},{"key":"5278_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.antiviral.2007.08.005","volume":"77","author":"BE Korba","year":"2008","unstructured":"Korba BE, Montero AB, Farrar K et al (2008) Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Antiviral Res 77:56\u201363","journal-title":"Antiviral Res"},{"key":"5278_CR55","first-page":"402","volume":"48","author":"PA Koul","year":"2000","unstructured":"Koul PA, Wahid A, Bhat MH et al (2000) Mepacrine therapy in niclosamide resistant taeniasis. J Assoc Physicians 48:402\u2013413","journal-title":"J Assoc Physicians"},{"key":"5278_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/archneur.1995.00540250109020","volume":"52","author":"LD Kramer","year":"1995","unstructured":"Kramer LD (1995) Medical treatment of cysticercosis: ineffective. Arch Neurol 52:101\u2013112","journal-title":"Arch Neurol"},{"key":"5278_CR57","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1148\/radiology.171.2.2704811","volume":"171","author":"LD Kramer","year":"1989","unstructured":"Kramer LD, Locke GE, Byrd SE, Daryabagi J (1989) Cerebral cysticercosis: documentation of natural history with CT. Radiology 171:459\u2013462","journal-title":"Radiology"},{"key":"5278_CR58","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s00018-008-8170-7","volume":"65","author":"M Krishna","year":"2008","unstructured":"Krishna M, Narang H (2008) The complexity of mitogen activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 65:3525\u20133544","journal-title":"Cell Mol Life Sci"},{"key":"5278_CR59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.actatropica.2012.03.008","volume":"123","author":"D Kulke","year":"2012","unstructured":"Kulke D, Krucken J, Welz C et al (2012) In vivo efficacy of the anthelmintic tribendimidine against the cestode Hymenolepis microstoma in a controlled laboratory trial. Acta Trop 123:78\u201384","journal-title":"Acta Trop"},{"key":"5278_CR60","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijid.2007.04.017","volume":"12","author":"M Lateef","year":"2008","unstructured":"Lateef M, Zargar SA, Khan AR et al (2008) Successful treatment of niclosamide and praziquantel-resistant beef tapeworm infection with nitazoxanide. Int J Infect Dis 12:80\u201382","journal-title":"Int J Infect Dis"},{"key":"5278_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.yebeh.2014.12.015","volume":"43","author":"A Leon","year":"2015","unstructured":"Leon A, Saito EK, Mehta B et al (2015) Calcified parenchymal central nervous system cysticercosis and clinical outcomes in epilepsy. Epilepsy Behav 43:77\u201380","journal-title":"Epilepsy Behav"},{"key":"5278_CR62","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1645\/GE-189R","volume":"90","author":"MZ Levine","year":"2004","unstructured":"Levine MZ, Calderon JC, Wilkins PP et al (2004) Characterization, cloning, and expression of two diagnostic antigens for Taenia solium tapeworm infection. J Parasitol 90:631\u2013638","journal-title":"J Parasitol"},{"key":"5278_CR63","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1645\/GE-938R.1","volume":"93","author":"MZ Levine","year":"2007","unstructured":"Levine MZ, Lewis MM, Rodriquez S et al (2007) Development of an enzyme-linked immune-electrotransfer blot (EITB) assay using two baculovirus expressed recombinant antigens for diagnosis of Taenia solium taeniasis. J Parasitol 93:409\u2013417","journal-title":"J Parasitol"},{"key":"5278_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1042\/BJ20081335","volume":"417","author":"V Levin-Salomon","year":"2009","unstructured":"Levin-Salomon V, Maayan I, Avrahami-Moyal L et al (2009) When expressed in yeast, mammalian mitogen-activated protein kinases lose proper regulation and become spontaneously phosphorylated. Biochem J 417:331\u2013340","journal-title":"Biochem J"},{"key":"5278_CR65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.vetpar.2006.05.015","volume":"141","author":"AH Li","year":"2006","unstructured":"Li AH, Moon SU, Park YK et al (2006) Identification and characterization of a cathepsin L-like cysteine protease from Taenia solium metacestode. Vet Parasitol 141:251\u2013259","journal-title":"Vet Parasitol"},{"key":"5278_CR66","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1017\/S003118201300111X","volume":"140","author":"T Li","year":"2013","unstructured":"Li T, Chen X, Yanagida T et al (2013) Detection of human taeniases in Tibetan endemic areas, China. Parasitology 140:1602\u20131607","journal-title":"Parasitology"},{"key":"5278_CR67","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","volume":"349","author":"Y Li","year":"2014","unstructured":"Li Y, Li PK, Robertsc MJ et al (2014) Multi-targeted therapy of cancer by niclosamide: a new application for an old drug. Cancer Lett 349:8\u201314","journal-title":"Cancer Lett"},{"key":"5278_CR68","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/pim.12291","volume":"38","author":"MW Lightowlers","year":"2016","unstructured":"Lightowlers MW, Garcia HH, Gauci CG et al (2016) Monitoring the outcomes of interventions against Taenia solium: options and suggestions. Parasite Immunol 38:158\u2013169","journal-title":"Parasite Immunol"},{"key":"5278_CR69","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1212\/WNL.57.10.1929","volume":"57","author":"M L\u00f3pez-G\u00f3mez","year":"2001","unstructured":"L\u00f3pez-G\u00f3mez M, Castro N, Jung H et al (2001) Optimization of the single-day praziquantel therapy for neurocysticercosis. Neurology 57:1929\u20131930","journal-title":"Neurology"},{"key":"5278_CR70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4419-6902-6_4","volume":"692","author":"NJ Marks","year":"2010","unstructured":"Marks NJ, Maule AG (2010) Neuropeptides in helminths: occurrence and distribution. Adv Exp Med Biol 692:49\u201377","journal-title":"Adv Exp Med Biol"},{"key":"5278_CR71","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1128\/JCM.01172-07","volume":"46","author":"H Mayta","year":"2008","unstructured":"Mayta H, Gilman RH, Prendergast E et al (2008) Nested PCR for specific diagnosis of Taenia solium taeniasis. J Clin Microbiol 46:286\u2013289","journal-title":"J Clin Microbiol"},{"key":"5278_CR72","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0001-706X(03)00056-1","volume":"87","author":"TE Nash","year":"2003","unstructured":"Nash TE (2003) Human case management and treatment of cysticercosis. Acta Trop 87:61\u201369","journal-title":"Acta Trop"},{"key":"5278_CR73","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0304-4017(02)00391-6","volume":"111","author":"A Nguekam","year":"2003","unstructured":"Nguekam A, Zoli AP, Vondou L et al (2003) Kinetics of circulating antigens in pigs experimentally infected with Taenia solium eggs. Vet Parasitol 111:323\u2013332","journal-title":"Vet Parasitol"},{"key":"5278_CR74","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1128\/JCM.00697-10","volume":"48","author":"A Nkouawa","year":"2010","unstructured":"Nkouawa A, Sako Y, Li T et al (2010) Evaluation of a loop-mediated isothermal amplification method using fecal specimens for differential detection of Taenia species from humans. J Clin Microbiol 48:3350\u20133352","journal-title":"J Clin Microbiol"},{"key":"5278_CR75","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.parint.2012.06.001","volume":"61","author":"A Nkouawa","year":"2012","unstructured":"Nkouawa A, Sako Y, Li T et al (2012) A loop mediated isothermal amplification method for a differential identification of Taenia tapeworms from human: application to a field survey. Parasitol Int 61:723\u2013725","journal-title":"Parasitol Int"},{"key":"5278_CR76","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1590\/S0036-46652006000100010","volume":"48","author":"CM Nunes","year":"2006","unstructured":"Nunes CM, Lima LG, Manoel CS et al (2006) Fecal specimens preparation methods for PCR diagnosis of human taeniosis. Rev Inst Med Trop Sao Paulo 48:45\u201347","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"5278_CR77","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1590\/S0036-46652005000400010","volume":"47","author":"SC Parija","year":"2005","unstructured":"Parija SC, Balamurungan N, Sahu PS et al (2005) Cysticercus antibodies and antigens in serum from blood donors from Pondicherry, India. Rev Inst Med Trop Sao Paulo 47:227\u2013230","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"5278_CR78","first-page":"20","volume-title":"WHO\/OIE manual on Echinococcosis in humans and animals: a public health problem of global concern","author":"ZS Paw\u0142owski","year":"2001","unstructured":"Paw\u0142owski ZS, Vuitton DA, Ammann RW et al (2001) Echinococcosis in humans: clinical aspects, diagnosis and treatment. In: Eckert J, Gemmell MA, Meslin FX et al (eds) WHO\/OIE manual on Echinococcosis in humans and animals: a public health problem of global concern. World Organization for Animal Health and World Health Organization, Paris, pp 20\u201371"},{"key":"5278_CR79","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/tmi.12089","volume":"18","author":"N Praet","year":"2013","unstructured":"Praet N, Verweij JJ, Mwape KE et al (2013) Bayesian modelling to estimate the test characteristics of coprology, coproantigen ELISA and a novel real-time PCR for the diagnosis of taeniasis. Trop Med Int Health 18:608\u2013614","journal-title":"Trop Med Int Health"},{"key":"5278_CR80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0035-9203(02)90423-2","volume":"96","author":"KN Prasad","year":"2002","unstructured":"Prasad KN, Chawla S, Jain D et al (2002) Human and porcine Taenia solium infection in rural north India. Trans R Soc Trop Med Hyg 96:515\u20136","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5278_CR81","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.trstmh.2007.04.019","volume":"101","author":"KN Prasad","year":"2007","unstructured":"Prasad KN, Prasad A, Gupta RK et al (2007) Prevalence and associated risk factors of T. solium taeniasis in a rural pig farming community of north India. Trans R Soc Trop Med Hyg 101:1241\u20131247","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5278_CR82","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s12038-008-0075-y","volume":"33","author":"KN Prasad","year":"2008","unstructured":"Prasad KN, Prasad A, Verma A et al (2008) Human cysticercosis and Indian scenario: a review. J Biosci 33:571\u2013580","journal-title":"J Biosci"},{"key":"5278_CR83","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.trstmh.2008.07.015","volume":"103","author":"KN Prasad","year":"2009","unstructured":"Prasad KN, Prasad A, Gupta RK et al (2009) Neurocysticercosis in patients with active epilepsy from a pig farming community. Trans R Soc Trop Med Hyg 103:144\u2013150","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5278_CR84","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1212\/01.wnl.0000249113.11824.64","volume":"67","author":"VM Rajshekhar","year":"2006","unstructured":"Rajshekhar VM, Raghava V, Prabhakaran V et al (2006) Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 67:2135\u20132139","journal-title":"Neurology"},{"key":"5278_CR85","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/vr.124.18.488","volume":"124","author":"E Rodriguez-del-Rosal","year":"1989","unstructured":"Rodriguez-del-Rosal E, Correa D, Flisser A (1989) Swine cysticercosis: detection of parasite products in serum. Vet Rec 124:488","journal-title":"Vet Rec"},{"issue":"110","key":"5278_CR86","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","volume":"2","author":"JF Rossignol","year":"2014","unstructured":"Rossignol JF (2014) Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res 2(110):94\u2013103","journal-title":"Antiviral Res"},{"key":"5278_CR87","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0035-9203(69)90128-X","volume":"63","author":"HH Salem","year":"1969","unstructured":"Salem HH, el-Allaf G (1969) Treatment of Taenia saginata and Hymenolepis nana infections with paromomycin. Trans R Soc Trop Med Hyg 63:833\u2013836","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5278_CR88","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(04)00705-7","volume":"3","author":"G Singh","year":"2004","unstructured":"Singh G, Sander J (2004) Anticysticercal treatment and seizures in neurocysticercosis. Lancet Neurol 3:207\u2013208","journal-title":"Lancet Neurol"},{"key":"5278_CR89","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/epi.12159","volume":"54","author":"G Singh","year":"2013","unstructured":"Singh G, Burneo JG, Sander JW (2013) From seizures to epilepsy and its substrates: neurocysticercosis. Epilepsia 54:783\u2013792","journal-title":"Epilepsia"},{"key":"5278_CR90","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/tropej\/49.5.274","volume":"49","author":"PD Singhi","year":"2003","unstructured":"Singhi PD, Dinakaran J, Khandelwal N et al (2003) One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. J Trop Pediatr 49:274\u2013278","journal-title":"J Trop Pediatr"},{"key":"5278_CR91","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jocn.2008.10.030","volume":"16","author":"S Sinha","year":"2009","unstructured":"Sinha S, Sharma BS (2009) Neurocysticercosis: a review of current status and management. J Clin Neurosci 16:867\u2013876","journal-title":"J Clin Neurosci"},{"key":"5278_CR92","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1128\/AAC.46.7.2116-2123.2002","volume":"46","author":"G Sisson","year":"2002","unstructured":"Sisson G, Goodwin A, Raudonikiene A et al (2002) Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother 46:2116\u20132123","journal-title":"Antimicrob Agents Chemother"},{"key":"5278_CR93","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198404193101601","volume":"310","author":"J Sotelo","year":"1984","unstructured":"Sotelo J, Escobedo F, Rodriguez-Carbajal J et al (1984) Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 310:1001\u20131007","journal-title":"N Engl J Med"},{"key":"5278_CR94","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1212\/WNL.35.5.752","volume":"35","author":"J Sotelo","year":"1985","unstructured":"Sotelo J, Torres B, Rubio-Donnadieu F et al (1985) Praziquantel in the treatment of neurocysticercosis: a long-term follow-up. Neurology 35:752\u2013755","journal-title":"Neurology"},{"key":"5278_CR95","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/archneur.1988.00520290064015","volume":"45","author":"J Sotelo","year":"1988","unstructured":"Sotelo J, Escobedo F, Penagos P (1988a) Albendazole vs. praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol 45:532\u2013534","journal-title":"Arch Neurol"},{"key":"5278_CR96","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/archneur.1988.00520340084017","volume":"45","author":"J Sotelo","year":"1988","unstructured":"Sotelo J, Penagos P, Escobedo F et al (1988b) Short course of albendazole therapy for neurocysticercosis. Arch Neurol 45:1130\u20131133","journal-title":"Arch Neurol"},{"key":"5278_CR97","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00314663","volume":"237","author":"J Sotelo","year":"1990","unstructured":"Sotelo J, Del Brutto OH, Penagos P et al (1990) Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 237:69\u201372","journal-title":"J Neurol"},{"key":"5278_CR98","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/archneur.1992.00530270106026","volume":"49","author":"OM Takayanagui","year":"1992","unstructured":"Takayanagui OM, Jardim E (1992) Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 49:290\u2013294","journal-title":"Arch Neurol"},{"key":"5278_CR99","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/35000065","volume":"2","author":"T Tanoue","year":"2000","unstructured":"Tanoue T, Adachi M, Moriguchi T et al (2000) A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol 2:110\u2013116","journal-title":"Nat Cell Biol"},{"key":"5278_CR100","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1017\/S0022149X14000455","volume":"89","author":"A Tembo","year":"2015","unstructured":"Tembo A, Craig PS (2015) Taenia saginata taeniosis: copro-antigen time-course in a voluntary self-infection. J Helminthol 89:612\u2013619","journal-title":"J Helminthol"},{"key":"5278_CR101","first-page":"10","volume":"1","author":"NV Terenina","year":"1998","unstructured":"Terenina NV, Kosovatova LA, Gerasimova E et al (1998) The effect of anthelmintics on the serotonin content of cestodes. Med Parazitol 1:10\u201315","journal-title":"Med Parazitol"},{"key":"5278_CR102","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature12031","volume":"496","author":"IJ Tsai","year":"2013","unstructured":"Tsai IJ, Zarowiecki M, Holroyd N (2013) The genomes of four tapeworm species reveal adaptations to parasitism. Nature 496:57\u201363","journal-title":"Nature"},{"key":"5278_CR103","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/infdis\/159.1.50","volume":"159","author":"VC Tsang","year":"1989","unstructured":"Tsang VC, Brand J, Boyer AE (1989) An enzyme-linked immune-electro transfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159:50\u201359","journal-title":"J Infect Dis"},{"key":"5278_CR104","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/archderm.1981.01650080061031","volume":"117","author":"EH Tschen","year":"1981","unstructured":"Tschen EH, Tschen EA, Smith EB (1981) Cutaneous cysticercosis treated with metrifonate. Arch Dermatol 117:507\u2013509","journal-title":"Arch Dermatol"},{"key":"5278_CR105","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tmaid.2008.06.006","volume":"6","author":"L VanNassauw","year":"2008","unstructured":"VanNassauw L, Toovey S, VanOpdenBosch J et al (2008) Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice. Travel Med Infect 6:253\u2013258","journal-title":"Travel Med Infect"},{"key":"5278_CR106","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1645\/GE-1191.1","volume":"93","author":"JA Vargas-Villavicencio","year":"2007","unstructured":"Vargas-Villavicencio JA, Larralde C, De Leon-Nava MA et al (2007) Tamoxifen treatment induces protection in murine cysticercosis. J Parasitol 93:1512\u20131517","journal-title":"J Parasitol"},{"key":"5278_CR107","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ijpara.2007.10.011","volume":"38","author":"JA Vargas-Villavicencio","year":"2008","unstructured":"Vargas-Villavicencio JA, Larralde C, Morales-Montor J (2008) Treatment with dehydroepiandrosterone in vivo and in vitro inhibits reproduction, growth and viability of Taenia crassiceps metacestodes. Int J Parasitol 38:775\u20137781","journal-title":"Int J Parasitol"},{"key":"5278_CR108","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0969-2126(01)00629-3","volume":"9","author":"Q Vicens","year":"2001","unstructured":"Vicens Q, Westhof E (2001) Crystal structure of paromomycin docked into the eubacterial ribosomal decoding a site. Structure 9:647\u2013658","journal-title":"Structure"},{"key":"5278_CR109","doi-asserted-by":"publisher","first-page":"e113239","DOI":"10.1371\/journal.pone.0113239","volume":"9","author":"NS Watts","year":"2014","unstructured":"Watts NS, Pajuelo M, Clark T et al (2014) Taenia solium infection in Peru: a collaboration between Peace Corps Volunteers and researchers in a community based study. PLoS One 9:e113239","journal-title":"PLoS One"},{"key":"5278_CR110","volume-title":"Guidelines for the surveillance, prevention and control of taeniosis\/cysticercosis","author":"WHO\/FAO\/OIE","year":"2005","unstructured":"WHO\/FAO\/OIE (2005) Guidelines for the surveillance, prevention and control of taeniosis\/cysticercosis. World Organization for Animal Health, Paris"},{"key":"5278_CR111","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4269\/ajtmh.1999.60.199","volume":"60","author":"PP Wilkins","year":"1999","unstructured":"Wilkins PP, Allan JC, Verastegui M et al (1999) Development of a serologic assay to detect Taenia solium taeniasis. Am J Trop Med Hyg 60:199\u2013204","journal-title":"Am J Trop Med Hyg"},{"key":"5278_CR112","unstructured":"Winkler AS, Richter H (2015) Landscape analysis: management of neurocysticercosis with an emphasis on low- and middle-income countries (LMIC). http:\/\/apps.who.int\/iris\/bitstream\/10665\/152896\/1\/WHO_HTM_NTD_NZD_2015.05_eng.pdf. Accessed 4 May 2015"},{"key":"5278_CR113","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/JCM.42.2.548-553.2004","volume":"42","author":"H Yamasaki","year":"2004","unstructured":"Yamasaki H, Allan JC, Sato MO et al (2004) DNA differential diagnosis of taeniasis and cysticercosis by multiplex PCR. J Clin Microbiol 42:548\u2013553","journal-title":"J Clin Microbiol"},{"key":"5278_CR114","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/1471-2164-15-428","volume":"15","author":"HB Yan","year":"2014","unstructured":"Yan HB, Lou Z, Li L et al (2014) Genome-wide analysis of regulatory proteases sequences identified through bioinformatics data mining in Taenia solium. BMC Genomics 15:428","journal-title":"BMC Genomics"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-016-5278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-016-5278-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-016-5278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T22:23:17Z","timestamp":1744064597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-016-5278-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["5278"],"URL":"https:\/\/doi.org\/10.1007\/s00436-016-5278-9","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]},"assertion":[{"value":"16 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}